Cracking the case: The diagnosis and treatment of a complex high-grade endometrial carcinoma with hepatoid, endometrioid, serous features and somatically derived yolk sac tumor component in a 50 year old female

Cailin O'Connell, Sylvia Jang, Paloma Monroig-Bosque, Anne Alaniz

Research output: Contribution to journalArticlepeer-review

Abstract

•Alpha-fetoprotein secreting tumors in gynecologic cancers have a broad differential.•Surgical pathology may provide a more comprehensive picture of tumor heterogeneity than initial biopsy.•Yolk Sac Tumor components intermixed with carcinoma points towards a somatic derivative rather than a collision tumor.•Alpha-fetoprotein can be trended over time to gauge response to treatment of cancers that produce the protein.

Original languageEnglish (US)
Article number101207
Pages (from-to)101207
JournalGynecologic Oncology Reports
Volume47
DOIs
StatePublished - Jun 2023

Keywords

  • Alpha-fetoprotein
  • Endometrial carcinoma
  • Endometroid
  • Hepatoid
  • Uterine cancer
  • Yolk sac tumor

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Cracking the case: The diagnosis and treatment of a complex high-grade endometrial carcinoma with hepatoid, endometrioid, serous features and somatically derived yolk sac tumor component in a 50 year old female'. Together they form a unique fingerprint.

Cite this